Dio Tree develops a novel small molecule for the treatment of ovarian cancer. The technology is based on inhibition of the enzyme DIO3, which is a major driver in many types of cancer, specifically ovarian cancer. The technology involves a series of small molecules targeting DIO3.
Cumulative Funding Raised Over Time ($)
Employees Over Time
DIO TREE Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Aug 10, 2023
www.calcalistech.com
"Imagine a scenario where a single drug could alter the course of a patient's battle with cancer" | CTech